ACMA Weekly
Accreditation Council for Medical Affairs (ACMA)
Life Sciences Accreditation & Certification. Medical Affairs, MSLs, Prior Auth, Biologics/Biosimilars
Highlight Article
Drug Launch and the Role of Medical Affairs - Click here to read!
Pharma Industry News Highlight
Innovative Research
Research in targeted cancer therapies is advancing, with significant strides in antisense oligonucleotides (ASOs) for treating cancer. These drugs aim to block harmful genetic messages that promote tumor growth, though delivery into cancer cells remains a challenge.
Clinical Trials
Neurocrine Biosciences reported positive Phase 2 data for its drug treating major depressive disorder, and Thermedical announced the completion of a feasibility study for treating cardiac arrhythmias using combined therapies.
Innovative Drug Development
There has been significant progress in the development of novel pharmaceutical compounds. Researchers are increasingly utilizing AI to discover new classes of antibiotics and other drugs. Notable developments include new treatments for pancreatic cancer and multiple sclerosis, as well as advanced methods targeting RNA medicines.
Emergence of Novel Modalities
The industry has seen a shift towards diverse therapeutic modalities beyond traditional small molecule drugs. Cell therapies, gene therapies, and mRNA-based treatments are becoming more prominent, though their financial impact on the industry is still evolving. These advanced therapies offer potential cures and significant improvements in patient outcomes but also come with high costs.
Become Board Certified in Medical Affairs
领英推荐
?? ACMA Webinar
ACMA Think Tank
Wondering how AI is reshaping medical affairs? Hear from industry leaders on these critical topics at the ACMA Think Tank.
Access Option: Live Stream or 40-page Report
The Must Have AI Tool for Every Medical Affairs Team!
Watch this video and learn how to use AI to transform your medical affairs organization's workflow.
About ACMA
The Accreditation Council for Medical Affairs (ACMA) is accredited by the International Association for Continuing Education and Training (IACET/ANSI) and is a member of the Institute for Credentialing Excellence (ICE).
Our mission is to establish standards of excellence in the life sciences.
ACMA has collaborated with over 200 pharma companies and individual professionals worldwide by helping them build capabilities in commercial, market access, and medical affairs support through certification, training, and AI tools.